Skip to content

To compare Quadratus Lumborum Type II block and Erector Spinae block for providing pain relief in patients undergoing Lower segment Caesarean section under Spinal Anaesthesia

Comparative Efficacy of Quadratus Lumborum Type II block and Erector Spinae block in patients undergoing Lower segment Caesarean section under Spinal Anaesthesia: A Randomised Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036750
Enrollment
52
Registered
2021-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Quadratus lumborum type II block with 0.25% Bupivacaine: The patient will be placed in right lateral position.Observing strict aseptic precautions, a curvilinear probe will be placed in

Sponsors

AIIMS RISHIKESH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult female patients, ASA physical status I and II undergoing Lower segment Caesarean section under Spinal Anaesthesia

Exclusion criteria

Exclusion criteria: Patientâ??s refusal for consent Patients with coagulation abnormalities Local infection at the site of nerve block History of musculoskeletal disorders or anatomical abnormalities History of psychiatric illness

Design outcomes

Primary

MeasureTime frame
Compare the total post-operative requirement of fentanyl in the first 24 hours after surgery with quadratus lumborum type II block and erector spinae block with 0.25% bupivacaine in patients undergoing Lower segment Caesarean section under Spinal AnaesthesiaTimepoint: 24 hours

Secondary

MeasureTime frame
Estimate the QoR15 scoresTimepoint: Post-operative day 1, 2 and on day of discharge;Compare the post-operative analgesia as measured by Numerical Rating ScoresTimepoint: At 6 hours and 24 hours;Compare the relative incidence of complicationsTimepoint: 24 hours

Countries

India

Contacts

Public ContactDR DEEPAK SINGLA

AIIMS,RISHIKESH

deepak10.4u@gmail.com9068504999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026